Pioneera Biosciences

Pioneera Biosciences is a San Diego-based biotechnology company specializing in the discovery and development of next-generation precision oncology therapeutics. Founded in 2021 by a team of veteran drug hunters from Turning Point Therapeutics, the company leverages deep expertise in structure-based drug design and medicinal chemistry to create highly selective small molecule inhibitors and targeted protein degraders (TPDs). Pioneera's proprietary platform is designed to overcome clinical resistance mechanisms in genetically defined cancers, targeting high-value oncogenic drivers that are underserved by current treatments. Currently in the pre-clinical stage, the company is advancing a pipeline of innovative candidates aimed at treating various solid tumors with high unmet medical needs. Backed by prominent investors such as Lilly Asia Ventures, Pioneera Biosciences is positioned as a leader in the next wave of precision medicine for cancer patients.